Document Detail


Progress in introduction of pneumococcal conjugate vaccine - worldwide, 2000-2012.
MedLine Citation:
PMID:  23615674     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
Pneumococcal conjugate vaccines (PCVs) are safe and effective for reducing illness and deaths caused by Streptococcus pneumoniae. Recommendations for PCV use from the World Health Organization (WHO) and funding from the GAVI Alliance have resulted in an increase in PCV introductions into national immunization programs, especially in lower-income countries. Additionally, new formulations that cover more serotypes commonly causing disease in lower- and middle-income countries have become available. This report uses WHO data from 2000-2012, stratified by country disease burden characteristics and World Bank country income groups, to describe global progress in PCV introduction. As of December 2012, a total of 86 (44%) WHO member states have added PCV to the routine infant immunization schedule of their national immunization programs; among those, 23 have introduced PCV with GAVI Alliance support. PCV introduction among WHO member states was most common in the Americas Region (60% of member states), followed by the Eastern Mediterranean Region (50%), European Region (49%), African Region (41%), and Western Pacific Region (33%); none of 11 WHO member states in the South-East Asia Region have introduced PCV. Proportions of low- and middle-income countries with PCV introductions were similar. The proportion of the world's birth cohort living in countries with PCV in national immunization programs increased from 1% in 2000 to 31% in 2012. These findings suggest that efforts to increase PCV introduction and use globally are succeeding; however, gaps in PCV use remain in Asia and countries with large birth cohorts, where concerted efforts should be focused.
Authors:
Related Documents :
21743294 - Informed consent in vaccination in india: medicolegal aspects.
23572484 - Heterologous ("nonspecific") and sex-differential effects of vaccines: epidemiology, cl...
24320154 - Learning from successful school-based vaccination clinics during 2009 ph1n1.
23402804 - Modelling the risk-benefit impact of h1n1 influenza vaccines.
1364024 - A study on the immune response of sheep to foot and mouth disease virus vaccine type 'o...
21743294 - Informed consent in vaccination in india: medicolegal aspects.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  MMWR. Morbidity and mortality weekly report     Volume:  62     ISSN:  1545-861X     ISO Abbreviation:  MMWR Morb. Mortal. Wkly. Rep.     Publication Date:  2013 Apr 
Date Detail:
Created Date:  2013-04-25     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7802429     Medline TA:  MMWR Morb Mortal Wkly Rep     Country:  United States    
Other Details:
Languages:  eng     Pagination:  308-11     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Obliterative bronchiolitis in workers in a coffee-processing facility - Texas, 2008-2012.
Next Document:  National shortage of purified-protein derivative tuberculin products.